Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial.
mild dyslipidemia
monacolin K
randomized clinical trial
red yeast rice
γ-aminobutyric acid
γ-oryzanol
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
31
07
2024
revised:
24
08
2024
accepted:
31
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
14
9
2024
Statut:
epublish
Résumé
The risk of cardiovascular disease (CVD) is approximately doubled in subjects with hypercholesterolemia compared to those with normal blood cholesterol levels. Monacolin K (MK), the main active substance in rice fermented by the
Identifiants
pubmed: 39275298
pii: nu16172983
doi: 10.3390/nu16172983
pii:
doi:
Substances chimiques
gamma-oryzanol
SST9XCL51M
Phenylpropionates
0
gamma-Aminobutyric Acid
56-12-2
Lovastatin
9LHU78OQFD
Cholesterol, LDL
0
Cholesterol, HDL
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM